A citation-based method for searching scientific literature

Francisco J Urbano, Mario R Pagani, Osvaldo D Uchitel. J Neuroimmunol 2008
Times Cited: 12







List of co-cited articles
61 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients.
M J Titulaer, P W Wirtz, J B M Kuks, H J Schelhaas, A J van der Kooi, C G Faber, W L van der Pol, M de Visser, P A E Sillevis Smitt, J J G M Verschuuren. J Neuroimmunol 2008
63
33


SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
L Sabater, M Titulaer, A Saiz, J Verschuuren, A O Güre, F Graus. Neurology 2008
123
25

Recommended diagnostic criteria for paraneoplastic neurological syndromes.
F Graus, J Y Delattre, J C Antoine, J Dalmau, B Giometto, W Grisold, J Honnorat, P Sillevis Smitt, Ch Vedeler, J J G M Verschuuren,[...]. J Neurol Neurosurg Psychiatry 2004
980
25

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.
F Graus, A Vincent, P Pozo-Rosich, L Sabater, A Saiz, B Lang, J Dalmau. J Neuroimmunol 2005
72
25

Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
Hannah L Pellkofer, Lena Armbruster, Markus Krumbholz, Maarten J Titulaer, Jan J Verschuuren, Friedrich Schumm, Raymond Voltz. J Neuroimmunol 2008
17
25

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
M Motomura, B Lang, I Johnston, J Palace, A Vincent, J Newsom-Davis. J Neurol Sci 1997
166
25

Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line.
A Roberts, S Perera, B Lang, A Vincent, J Newsom-Davis. Nature 1985
214
25

Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome.
J J Verschuuren, J Dalmau, R Tunkel, B Lang, F Graus, L Schramm, J B Posner, J Newsom-Davis, M R Rosenfeld. Neurology 1998
31
25


Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.
Maarten J Titulaer, Paul Maddison, Jacob K Sont, Paul W Wirtz, David Hilton-Jones, Rinse Klooster, Nick Willcox, Marko Potman, Peter A E Sillevis Smitt, Jan B M Kuks,[...]. J Clin Oncol 2011
79
25

Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
W P Mason, F Graus, B Lang, J Honnorat, J Y Delattre, F Valldeoriola, J C Antoine, M K Rosenblum, M R Rosenfeld, J Newsom-Davis,[...]. Brain 1997
231
25

Guidelines for treatment of autoimmune neuromuscular transmission disorders.
G O Skeie, S Apostolski, A Evoli, N E Gilhus, I Illa, L Harms, D Hilton-Jones, A Melms, J Verschuuren, H W Horge. Eur J Neurol 2010
199
25

The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland.
Paul W Wirtz, Marianne G Nijnuis, Mohammad Sotodeh, Luc N A Willems, Joey J Brahim, Hein Putter, Axel R Wintzen, Jan J Verschuuren. J Neurol 2003
59
25

SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Maarten J Titulaer, Rinse Klooster, Marko Potman, Lidia Sabater, Francesc Graus, Ingrid M Hegeman, Peter E Thijssen, Paul W Wirtz, Albert Twijnstra, Peter A E Sillevis Smitt,[...]. J Clin Oncol 2009
114
25

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
Maria Isabel Leite, Saiju Jacob, Stuart Viegas, Judy Cossins, Linda Clover, B Paul Morgan, David Beeson, Nick Willcox, Angela Vincent. Brain 2008
285
16

Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study.
P W Wirtz, J J Verschuuren, J G van Dijk, M L de Kam, R C Schoemaker, J G C van Hasselt, M J Titulaer, U R Tjaden, J den Hartigh, J M A van Gerven. Clin Pharmacol Ther 2009
77
16

Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome.
Maarten J Titulaer, Paul W Wirtz, Luuk N A Willems, Klaas W van Kralingen, Peter A E Sillevis Smitt, Jan J G M Verschuuren. J Clin Oncol 2008
65
16

Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome.
Shin J Oh, Katsumi Kurokawa, Gwen C Claussen, Hewitt F Ryan. Muscle Nerve 2005
87
16

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
V A Lennon, T J Kryzer, G E Griesmann, P E O'Suilleabhain, A J Windebank, A Woppmann, G P Miljanich, E H Lambert. N Engl J Med 1995
407
16

Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
K Leys, B Lang, I Johnston, J Newsom-Davis. Ann Neurol 1991
126
16

Lambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancer.
Paul W Wirtz, Axel R Wintzen, Jan J Verschuuren. Muscle Nerve 2005
35
16

HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
Paul W Wirtz, Nick Willcox, Arno R van der Slik, Bethan Lang, Paul Maddison, Bobby P C Koeleman, Marius J Giphart, Axel R Wintzen, Bart O Roep, Jan J G M Verschuuren. J Neuroimmunol 2005
55
16



Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
L A Hoffmann, S Jarius, H L Pellkofer, M Schueller, M Krumbholz, F Koenig, W Johannis, C la Fougere, T Newman, A Vincent,[...]. J Neurol Neurosurg Psychiatry 2008
110
16

Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms.
Maarten J Titulaer, Jan J G M Verschuuren. Ann N Y Acad Sci 2008
44
16

Regulatory T cells in paraneoplastic neurological syndromes.
Takashi Tani, Keiko Tanaka, Jiro Idezuka, Masatoyo Nishizawa. J Neuroimmunol 2008
39
16

Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.
M J Titulaer, R Soffietti, J Dalmau, N E Gilhus, B Giometto, F Graus, W Grisold, J Honnorat, P A E Sillevis Smitt, R Tanasescu,[...]. Eur J Neurol 2011
257
16

Treatment for Lambert-Eaton myasthenic syndrome.
Michael Keogh, Saam Sedehizadeh, Paul Maddison. Cochrane Database Syst Rev 2011
53
16

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Paul Maddison, John McConville, Maria Elena Farrugia, Nicholas Davies, Michael Rose, Fiona Norwood, Heinz Jungbluth, Stephanie Robb, David Hilton-Jones. J Neurol Neurosurg Psychiatry 2011
67
16

Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients.
G M Elrington, N M Murray, S G Spiro, J Newsom-Davis. J Neurol Neurosurg Psychiatry 1991
123
16

A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome.
D B Sanders, J M Massey, L L Sanders, L J Edwards. Neurology 2000
114
16

3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS.
Shin J Oh, Gwendolyn G Claussen, Yuki Hatanaka, Marla B Morgan. Muscle Nerve 2009
58
16


Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons.
Zhen Yan, Ping Chi, James A Bibb, Timothy A Ryan, Paul Greengard. J Physiol 2002
83
16


Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
Miranda Payne, Penny Bradbury, Bethan Lang, Angela Vincent, Cheng Han, John Newsom-Davis, Denis Talbot. J Thorac Oncol 2010
31
16

(R)-roscovitine prolongs the mean open time of unitary N-type calcium channel currents.
N R DeStefino, A A Pilato, M Dittrich, S V Cherry, S Cho, J R Stiles, S D Meriney. Neuroscience 2010
19
16

Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Maarten J Titulaer, Bethan Lang, Jan Jgm Verschuuren. Lancet Neurol 2011
157
16


Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
Peter Sillevis Smitt, Joost Grefkens, Bertie de Leeuw, Martin van den Bent, Wim van Putten, Herbert Hooijkaas, Charles Vecht. J Neurol 2002
136
16


A case of spontaneous regression of small cell lung cancer with progression of paraneoplastic sensory neuropathy.
Satoshi Hirano, Yoshifumi Nakajima, Eriko Morino, Yuji Fujikura, Makoto Mochizuki, Yuichiro Takeda, Haruhito Sugiyama, Nobuyuki Kobayashi, Keiko Tanaka, Koichiro Kudo. Lung Cancer 2007
15
16

The anti-Hu syndrome: a clinical and immunological study of 7 cases.
F Pieret, C J Sindic, M P Chalon, M Warny, S Bolyn, I Dehaene, Y Gobiet, S Goka, P Laloux, P Monteyne,[...]. Acta Neurol Belg 1996
11
18



A follow up study of patients with paraneoplastic neurological disease in the United Kingdom.
P M Candler, P E Hart, M Barnett, R Weil, J H Rees. J Neurol Neurosurg Psychiatry 2004
80
16

Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
M Uchuya, F Graus, F Vega, R Reñé, J Y Delattre. J Neurol Neurosurg Psychiatry 1996
148
16

Paraneoplastic sensory neuronopathy and spontaneous regression of small cell lung cancer.
Sharlene Gill, Nevin Murray, Josep Dalmau, Brian Thiessen. Can J Neurol Sci 2003
35
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.